Related Experiment Video
Updated: Jul 16, 2026
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
The Mutational Landscape of Acute Myeloid Leukemia and Its Impact
Tarindhi Ratnayake1, Clifford Liongue1,2, Alister C Ward1,2
1School of Medicine, Deakin University, Waurn Ponds, Geelong, VIC 3216, Australia.
Abstract:
Acute myeloid leukemia (AML) is one of the most common types of hematological malignancies and a leading cause of cancer deaths. It is characterized by the rapid accumulation of typically immature myeloid cells that serve to disrupt the production of mature cells, leading to a range of clinical sequelae. The role of recurrent chromosomal aberrations has long been appreciated in this disease, but a myriad of gene mutations have been increasingly acknowledged as having important roles. This review provides a comprehensive overview of the mutational landscape of AML, discussing the various genetic lesions in terms of their function, classification, etiological role, prognostic value, therapeutic impact, detection, and monitoring, with a particular focus on gene mutations.
Insights
This review details gene mutations in acute myeloid leukemia (AML), a common blood cancer. Understanding these genetic changes is crucial for diagnosis, prognosis, and developing targeted AML therapies.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Acute myeloid leukemia (AML) is a prevalent hematological malignancy and a significant cause of cancer mortality.
- AML is defined by the rapid proliferation of immature myeloid cells, impairing normal blood cell production and leading to severe clinical issues.
- While chromosomal abnormalities are recognized, gene mutations are increasingly understood to play critical roles in AML pathogenesis.
Purpose of the Study:
- To provide a comprehensive review of the mutational landscape in AML.
- To discuss the functional, etiological, prognostic, and therapeutic implications of various genetic lesions in AML.
- To highlight the importance of gene mutations in the detection and monitoring of AML.
Main Methods:
- Literature review of studies on AML genetics.
- Analysis of gene mutations in relation to AML.
- Synthesis of information on mutation function, classification, and clinical impact.
Main Results:
- Identified a wide spectrum of gene mutations implicated in AML.
- Detailed the functional roles and classification of these genetic alterations.
- Summarized the etiological significance, prognostic value, and therapeutic relevance of AML-associated gene mutations.
Conclusions:
- Gene mutations are central to understanding AML biology and progression.
- Comprehensive knowledge of the AML mutational landscape is essential for improved patient outcomes.
- Targeted strategies focusing on specific gene mutations hold promise for AML treatment and monitoring.
